Mental Disorders in Primary Care A Guide to their Evaluation and Management

Mental disorders are highly prevalent in the primary care setting, yet are frequently misdiagnosed and often inappropriately treated. The presence of unrecognized or misdiagnosed mental disorders is associated with increased service utilization and health care costs, and can significantly impact the patient's quality of life and risk of suicide. Written by experts from around the world, Mental Disorders in Primary Care offers readers with a comprehensive and evidence-based guide to the diagnosis and treatment of mental disorders in the primary care setting. Containing 21 chapters on a variety of psychiatric disorders, such as depressive disorders and substance use disorders, and key topics for discussion such as drug interactions, and collaborative care, Mental Disorders in Primary Care is essential reading for clinicians treating patients in a primary care setting. Fully up-to-date to reflect DSM-5's taxonomy of psychiatric disorders, this resource provides readers with a global and comprehensive guide to the diagnosis and treatment of patients with mental disorders.

1 - The epidemiology and burden of mental disorders in primary care
2 - Across the spectrum: strategies to improve recognition and treatment of mental disorders in primary care
3 - Collaborative care models for the management of mental disorders in primary care
4 - Operationalising patient-centredness to enhance recovery and primary care for mental disorders.
5 - Neurobiological aspects of mental disorders
6 - The DSM-5: what should general practitioners know?
7 - Anxiety disorders in primary care
8 - ADHD across the lifespan
9 - Trauma and stressor-related disorders
10 - Depressive disorders
11 - Bipolar disorder
12 - Suicide and suicidal behaviour
13 - Somatic symptom and related disorders
14 - Substance use disorders in primary care settings
15 - Motivational interviewing: its role for the management of mental disorders in primary care
16 - Psychosis
17 - Late-life depression
18 - Psychotherapeutic interventions
19 - Major depressive disorder: how to evaluate and manage patients with psychiatric and medical comorbidities?
20 - Untoward side effects of psychiatric drugs
21 - Drug interactions involving psychotropic drugs

André F. Carvalho, MD, PhD is Associate Professor of Psychiatry and Head of the Translational Psychiatry Research Group at the Faculty of Medicine of Federal University of Ceará (Brazil). He has been elected to the board of councilors of the International Society of Bipolar Disorders (ISBD) and is also the elected vice-chair of the section of private practice psychiatry of the World Psychiatric Association (WPA). He sits on the editorial board of several international peer-reviewed journals, including Psychotherapy and Psychosomatics. He has served as a peer-reviewer for several leading journals and funding agencies. Roger S. McIntyre is Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. He is involved in multiple research endeavours which primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity. His works broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment. Roger McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association